Altria (MO) Likely to see Upside from the Pending MO / JUUL Trial - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Pamela Kaufman reiterated an Overweight rating and $52.00 price target on Altria (NYSE: MO) ahead of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
